Published in Neurosci Lett on September 16, 2004
Neurotrophic and neuroprotective actions of estrogen: basic mechanisms and clinical implications. Steroids (2007) 2.56
MAPK signaling is critical to estradiol protection of CA1 neurons in global ischemia. Endocrinology (2006) 1.29
Acute and chronic estradiol treatments reduce memory deficits induced by transient global ischemia in female rats. Horm Behav (2005) 1.07
Glutamate-induced apoptosis in primary cortical neurons is inhibited by equine estrogens via down-regulation of caspase-3 and prevention of mitochondrial cytochrome c release. BMC Neurosci (2005) 0.98
The potential for estrogens in preventing Alzheimer's disease and vascular dementia. Ther Adv Neurol Disord (2009) 0.87
Pretreatment with a single estradiol-17beta bolus activates cyclic-AMP response element binding protein and protects CA1 neurons against global cerebral ischemia. Neuroscience (2009) 0.86
Female Rats Demonstrate Improved Locomotor Recovery and Greater Preservation of White and Gray Matter after Traumatic Spinal Cord Injury Compared to Males. J Neurotrauma (2015) 0.83
Effects of hormone therapy on cognition and mood. Fertil Steril (2014) 0.81
Acute pretreatment with estradiol protects against CA1 cell loss and spatial learning impairments resulting from transient global ischemia. Horm Behav (2006) 0.80
The effects of soy extract on spatial learning and memory damage induced by global ischemia in ovariectomised rats. Malays J Med Sci (2014) 0.80
Periodic 17β-estradiol pretreatment protects rat brain from cerebral ischemic damage via estrogen receptor-β. PLoS One (2013) 0.79
Does being female provide a neuroprotective advantage following spinal cord injury? Neural Regen Res (2015) 0.78
Effects of Estrogen and Phytoestrogen Treatment on an In Vitro Model of Recurrent Stroke on HT22 Neuronal Cell Line. Cell Mol Neurobiol (2016) 0.77
Estrogen therapy increases BDNF expression and improves post-stroke depression in ovariectomy-treated rats. Exp Ther Med (2016) 0.75
Illicit drug use in cluster headache patients and in the general population: a comparative cross-sectional survey. Cephalalgia (2012) 2.48
Spontaneous intracranial hypotension syndrome: report of twelve cases. Headache (2004) 2.26
Pain as a nonmotor symptom of Parkinson disease: evidence from a case-control study. Arch Neurol (2008) 1.96
Post-ischemic brain damage: pathophysiology and role of inflammatory mediators. FEBS J (2009) 1.95
Migraine and psychiatric comorbidity: a review of clinical findings. J Headache Pain (2011) 1.75
Diagnostic delay and suboptimal management in a referral population with hemicrania continua. Headache (2009) 1.54
From clinical evidence to molecular mechanisms underlying neuroprotection afforded by estrogens. Pharmacol Res (2005) 1.40
Relationship between hallucinations, delusions, and rapid eye movement sleep behavior disorder in Parkinson's disease. Mov Disord (2005) 1.20
Diagnostic and therapeutic errors in trigeminal autonomic cephalalgias and hemicrania continua: a systematic review. J Headache Pain (2013) 1.16
REM behavior disorder, hallucinations and cognitive impairment in Parkinson's disease: a two-year follow up. Mov Disord (2008) 1.15
Diagnostic and therapeutic errors in cluster headache: a hospital-based study. J Headache Pain (2014) 1.14
Neuropharmacology of the essential oil of bergamot. Fitoterapia (2010) 1.13
Early and long-term outcome of rehabilitation in stroke patients: the role of patient characteristics, time of initiation, and duration of interventions. Arch Phys Med Rehabil (2003) 1.11
Italian guidelines for primary headaches: 2012 revised version. J Headache Pain (2012) 1.10
Effects of diffuse noxious inhibitory controls on temporal summation of the RIII reflex in humans. Pain (2004) 1.08
Involvement of the endocannabinoid system in retinal damage after high intraocular pressure-induced ischemia in rats. Invest Ophthalmol Vis Sci (2007) 1.07
17Beta-estradiol prevents retinal ganglion cell loss induced by acute rise of intraocular pressure in rat. Prog Brain Res (2008) 1.06
Transplantation of undifferentiated human mesenchymal stem cells protects against 6-hydroxydopamine neurotoxicity in the rat. Cell Transplant (2009) 1.05
Chemical and biological properties of toxic metals and use of chelating agents for the pharmacological treatment of metal poisoning. Arch Toxicol (2010) 1.05
Immune-mediated neuropathies in myeloma patients treated with bortezomib. Clin Neurophysiol (2008) 1.04
A narrative review on the management of medication overuse headache: the steep road from experience to evidence. J Headache Pain (2009) 1.03
REM sleep behavior disorder, hallucinations, and cognitive impairment in Parkinson's disease. Mov Disord (2006) 1.03
Expression polymorphism of the blood-brain barrier component P-glycoprotein (MDR1) in relation to Parkinson's disease. Pharmacogenetics (2002) 1.02
Multiple neurogenic and neurorescue effects of human mesenchymal stem cell after transplantation in an experimental model of Parkinson's disease. Brain Res (2009) 1.02
Hypolipemic and hypoglycaemic activity of bergamot polyphenols: from animal models to human studies. Fitoterapia (2010) 1.02
Nitroglycerin induces hyperalgesia in rats--a time-course study. Eur J Pharmacol (2003) 0.99
Time-course of nigrostriatal damage, basal ganglia metabolic changes and behavioural alterations following intrastriatal injection of 6-hydroxydopamine in the rat: new clues from an old model. Eur J Neurosci (2007) 0.99
Gemcitabine-loaded PEGylated unilamellar liposomes vs GEMZAR: biodistribution, pharmacokinetic features and in vivo antitumor activity. J Control Release (2010) 0.98
Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism. Mov Disord (2003) 0.97
Use of complementary and alternative medicine by patients with chronic tension-type headache: results of a headache clinic survey. Headache (2006) 0.97
From drug-induced headache to medication overuse headache. A short epidemiological review, with a focus on Latin American countries. J Headache Pain (2009) 0.97
Botulinum toxin and neuromotor rehabilitation: An integrated approach to idiopathic cervical dystonia. Mov Disord (2006) 0.97
Drug prescribing patterns in Parkinson's disease: a pharmacoepidemiological survey in a cohort of ambulatory patients. Pharmacoepidemiol Drug Saf (2002) 0.96
Botulinum toxin type-A in the prophylactic treatment of medication-overuse headache: a multicenter, double-blind, randomized, placebo-controlled, parallel group study. J Headache Pain (2011) 0.95
N-acetylcysteine prevents HIV gp 120-related damage of human cultured astrocytes: correlation with glutamine synthase dysfunction. BMC Neurosci (2007) 0.95
Autophagy impairment in a mouse model of neuropathic pain. Mol Pain (2011) 0.95
Long-term observational, non-randomized study of enzyme replacement therapy in late-onset glycogenosis type II. J Inherit Metab Dis (2010) 0.95
Electrophysiological evidence for trigeminal neuron sensitization in patients with migraine. Neurosci Lett (2002) 0.95
Deep brain stimulation and cognitive functions in Parkinson's disease: A three-year controlled study. Mov Disord (2009) 0.94
The effect of inflammatory stimuli on NMDA-related activation of glutamine synthase in human cultured astroglial cells. Neurosci Lett (2004) 0.94
Oral nitric-oxide donor glyceryl-trinitrate induces sensitization in spinal cord pain processing in migraineurs: a double-blind, placebo-controlled, cross-over study. Eur J Pain (2010) 0.93
Bartonella quintana lipopolysaccharide effects on leukocytes, CXC chemokines and apoptosis: a study on the human whole blood and a rat model. Int Immunopharmacol (2003) 0.93
Effects of lipid composition and preparation conditions on physical-chemical properties, technological parameters and in vitro biological activity of gemcitabine-loaded liposomes. Curr Drug Deliv (2007) 0.92
Seizure susceptibility to various convulsant stimuli in dystrophin-deficient mdx mice. Neurosci Res (2004) 0.91
Intraplantar injection of bergamot essential oil induces peripheral antinociception mediated by opioid mechanism. Pharmacol Biochem Behav (2010) 0.91
The role of oxidative stress in paraquat-induced neurotoxicity in rats: protection by non peptidyl superoxide dismutase mimetic. Neurosci Lett (2003) 0.91
Temporal profile of vascular changes induced by systemic nitroglycerin in the meningeal and cortical districts. Cephalalgia (2010) 0.91
Childhood and adolescent migraine: a neuropsychiatric disorder? Med Hypotheses (2011) 0.91
Identification of novel pharmacological targets to minimize excitotoxic retinal damage. Int Rev Neurobiol (2009) 0.90
Oxidative stress and pro-apoptotic conditions in a rodent model of Wilson's disease. Biochim Biophys Acta (2005) 0.90
Prolonged blockade of NMDA or mGluR5 glutamate receptors reduces nigrostriatal degeneration while inducing selective metabolic changes in the basal ganglia circuitry in a rodent model of Parkinson's disease. Neurobiol Dis (2005) 0.90
Focus on therapy: hemicrania continua and new daily persistent headache. J Headache Pain (2010) 0.89
Identification of distinct cellular pools of interleukin-1beta during the evolution of the neuroinflammatory response induced by transient middle cerebral artery occlusion in the brain of rat. Brain Res (2009) 0.89
An electronic diary on a palm device for headache monitoring: a preliminary experience. J Headache Pain (2012) 0.89
Evidence to implicate early modulation of interleukin-1beta expression in the neuroprotection afforded by 17beta-estradiol in male rats undergone transient middle cerebral artery occlusion. Int Rev Neurobiol (2007) 0.88
The antidote effect of quinone oxidoreductase 2 inhibitor against paraquat-induced toxicity in vitro and in vivo. Br J Pharmacol (2013) 0.88
The interplay of two single nucleotide polymorphisms in the CACNA1A gene may contribute to migraine susceptibility. Neurosci Lett (2009) 0.88
Endothelial nitric oxide synthase is segregated from caveolin-1 and localizes to the leading edge of migrating cells. Exp Cell Res (2006) 0.88
Intraplantar injection of bergamot essential oil into the mouse hindpaw: effects on capsaicin-induced nociceptive behaviors. Int Rev Neurobiol (2009) 0.87
Activation of the transcription factor NF-kappaB in the nucleus trigeminalis caudalis in an animal model of migraine. Neurotoxicology (2005) 0.87
Pisa syndrome in Parkinson's disease: clinical, electromyographic, and radiological characterization. Mov Disord (2011) 0.87
The Tat antagonist neomycin B hexa-arginine conjugate inhibits gp-120-induced death of human neuroblastoma cells. J Neurochem (2003) 0.87
The contribution of oxidative stress in apoptosis of human-cultured astroglial cells induced by supernatants of HIV-1-infected macrophages. J Leukoc Biol (2002) 0.87
Biomarkers of oxidation, inflammation and cartilage degradation in osteoarthritis patients undergoing sulfur-based spa therapies. Clin Biochem (2010) 0.87
Implication of limonene and linalyl acetate in cytotoxicity induced by bergamot essential oil in human neuroblastoma cells. Fitoterapia (2013) 0.87
Effect of sex and estrogens on neuronal activation in an animal model of migraine. Headache (2012) 0.87
Interaction between Apolipoprotein epsilon 4 and traumatic brain injury in patients with Alzheimer's disease and Mild Cognitive Impairment. Funct Neurol (2007) 0.87
Use of complementary and alternative medicine by patients with cluster headache: results of a multi-centre headache clinic survey. Complement Ther Med (2007) 0.87
Activation of CB2 receptors as a potential therapeutic target for migraine: evaluation in an animal model. J Headache Pain (2014) 0.86
A role for brain cyclooxygenase-2 and prostaglandin-E2 in migraine: effects of nitroglycerin. Int Rev Neurobiol (2007) 0.86
Evidence implicating matrix metalloproteinases in the mechanism underlying accumulation of IL-1beta and neuronal apoptosis in the neocortex of HIV/gp120-exposed rats. Int Rev Neurobiol (2007) 0.86
Cerebrospinal fluid levels of tau phosphorylated at threonine 181 in patients with Alzheimer's disease and vascular dementia. Neurol Sci (2008) 0.86
Effects of anandamide in migraine: data from an animal model. J Headache Pain (2011) 0.86
The effects of alcohol on cognition in the elderly: from protection to neurodegeneration. Funct Neurol (2011) 0.85
Hypertension and migraine comorbidity: prevalence and risk of cerebrovascular events: evidence from a large, multicenter, cross-sectional survey in Italy (MIRACLES study). J Hypertens (2011) 0.85
Reproductive life milestones in women with Parkinson's disease. Funct Neurol (2004) 0.85
Systemic administration of an mGluR5 antagonist, but not unilateral subthalamic lesion, counteracts l-DOPA-induced dyskinesias in a rodent model of Parkinson's disease. Neurobiol Dis (2007) 0.85
The protective effect of superoxide dismutase mimetic M40401 on balloon injury-related neointima formation: role of the lectin-like oxidized low-density lipoprotein receptor-1. J Pharmacol Exp Ther (2004) 0.85
Prevention of Glutamate Accumulation and Upregulation of Phospho-Akt may Account for Neuroprotection Afforded by Bergamot Essential Oil against Brain Injury Induced by Focal Cerebral Ischemia in Rat. Int Rev Neurobiol (2009) 0.85
Dopaminergic modulation of oxidative stress and apoptosis in human peripheral blood lymphocytes: evidence for a D1-like receptor-dependent protective effect. Free Radic Biol Med (2004) 0.85
Central components of the analgesic/antihyperalgesic effect of nimesulide: studies in animal models of pain and hyperalgesia. Drugs (2003) 0.84
Overexpression of superoxide dismutase 1 protects against beta-amyloid peptide toxicity: effect of estrogen and copper chelators. Neurochem Int (2004) 0.84
Peripherally injected linalool and bergamot essential oil attenuate mechanical allodynia via inhibiting spinal ERK phosphorylation. Pharmacol Biochem Behav (2012) 0.84
Enhanced anandamide degradation is associated with neuronal apoptosis induced by the HIV-1 coat glycoprotein gp120 in the rat neocortex. J Neurochem (2004) 0.84
Peripheral inflammation and neuroprotection: systemic pretreatment with complete Freund's adjuvant reduces 6-hydroxydopamine toxicity in a rodent model of Parkinson's disease. Neurobiol Dis (2006) 0.84
The angiotensin-converting enzyme insertion/deletion polymorphism modifies the clinical outcome in patients with Pompe disease. Genet Med (2010) 0.84
Dysphagia in multiple sclerosis: from pathogenesis to diagnosis. Neurol Sci (2008) 0.84
Prostaglandins, glutamate and nitric oxide synthase mediate nitroglycerin-induced hyperalgesia in the formalin test. Eur J Pharmacol (2006) 0.84
Rational basis for the development of coenzyme Q10 as a neurotherapeutic agent for retinal protection. Prog Brain Res (2008) 0.83